Immediate Impact
4 from Science/Nature 52 standout
Citing Papers
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
Works of Pip Patrick being referenced
RESPONSE‐ADJUSTED THERAPY FOR ADVANCED HODGKIN LYMPHOMA (RATHL) TRIAL: LONGER FOLLOW UP CONFIRMS EFFICACY OF DE‐ESCALATION AFTER a NEGATIVE INTERIM PET SCAN (CRUK/07/033).
2017
Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Pip Patrick | 328 | 262 | 202 | 26 | 590 | |
| Laura Clifton‐Hadley | 312 | 183 | 136 | 50 | 550 | |
| J.P. Vannier | 262 | 182 | 101 | 24 | 644 | |
| CR Kjeldsberg | 509 | 341 | 66 | 23 | 707 | |
| Judith E. Powell | 230 | 226 | 87 | 17 | 695 | |
| Santiago Mercadal | 545 | 390 | 63 | 55 | 681 | |
| Valentina Gianfelici | 134 | 167 | 278 | 29 | 720 | |
| Guido Gini | 233 | 202 | 61 | 36 | 612 | |
| Finlay MacDougall | 363 | 348 | 71 | 13 | 665 | |
| O. Pate | 376 | 277 | 75 | 13 | 572 | |
| P. J. Bierman | 346 | 246 | 57 | 20 | 602 |
All Works
Loading papers...